Bristol Myers Squibb and Bain Capital have formed a new independent biopharmaceutical company focused on developing new ...

TripAdvisor cofounder Steve Kaufer stepped down as CEO in 2022. Since then, he says some people have stopped responding to ...

Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...

Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives, Dan Lynch, and ...

Bristol Myers Squibb is spinning off a fresh company armed with five autoimmune disease drugs and $300 million in Bain ...

The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which will retain 20% equity in the new company.

The $3 bln education publisher McGraw Hill and $6 bln research firm NIQ thudded onto the market this week. Both lose money ...